Quest Diagnostics

Yahoo Finance • 6 days ago

Notable healthcare headlines for the week: Pfizer, Novo Nordisk and JNJ in focus

Wall Street’s broader market averages closed mixed on Friday as market participants digested the U.S. government shutdown for the third day. For the week, the Dow, S&P 500, and Nasdaq Composite advanced by 1.1%, 1.08%, and 1.32%, respecti... Full story

Yahoo Finance • 10 days ago

Ex-Dividend Reminder: Quest Diagnostics, Bristol Myers Squibb and Globe Life

Looking at the universe of stocks we cover at Dividend Channel, on 10/3/25, Quest Diagnostics, Inc. (Symbol: DGX), Bristol Myers Squibb Co. (Symbol: BMY), and Globe Life Inc (Symbol: GL) will all trade ex-dividend for their respective upco... Full story

Yahoo Finance • 12 days ago

Why Guardant Health (GH) Stock Is Trading Up Today

What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion diagnostic for Eli Lilly... Full story

Yahoo Finance • 12 days ago

Government shutdown looms: SA spotlights 20 defensive dividend stocks in response

[Donkey and Elephant Tug of War for the White House] JimLarkin Congress faces a critical deadline this week as the U.S. government edges closer to a potential shutdown. Lawmakers must reach a funding agreement by 12:01 a.m. Wednesday to a... Full story

Yahoo Finance • 24 days ago

Quest Diagnostics Incorporated (DGX): A Bull Case Theory

We came across a bullish thesis on Quest Diagnostics Incorporated on Valueinvestorsclub.com by cuyler1903. In this article, we will summarize the bulls’ thesis on DGX. Quest Diagnostics Incorporated 's share was trading at $180.14 as of Se... Full story

Yahoo Finance • 26 days ago

US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic

Company Logo The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from US$ 2 billion in 2024, reflecting a CAGR of 7.11% from 2025 to 2033. This growth is driven by increasi... Full story

Yahoo Finance • last month

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Opendoor Technologies Inc. 136,631,575 7.32 6.86 6.875 +0.225 Eightco Ho... Full story

Yahoo Finance • last month

Quest Diagnostics: A Solid Investment or a Risky Bet?

Explore the exciting world of Quest Diagnostics(NYSE: DGX) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opport... Full story

Yahoo Finance • last month

How Investors May Respond To Quest Diagnostics (DGX) Expanding Michigan Lab Services Through Corewell Joint Venture

Corewell Health and Quest Diagnostics recently announced a definitive agreement to form a joint venture, Diagnostic Lab of Michigan, which will expand innovative and affordable laboratory services across Michigan using advanced technologie... Full story

Yahoo Finance • last month

10 dividend stocks to watch as the S&P 500 notches a new record high

[digital candlestick chart with bollinger bands and colorful ai indicators for market volatility, crypto trading, and fintech innovation] primeimages/iStock via Getty Images Wall Street climbed on Wednesday, with the S&P 500 (SP500 [https... Full story

Yahoo Finance • last month

American Eagle Outfitters Breaks Above 200-Day Moving Average - Bullish for AEO

In trading on Wednesday, shares of American Eagle Outfitters, Inc. (Symbol: AEO) crossed above their 200 day moving average of $13.28, changing hands as high as $13.36 per share. American Eagle Outfitters, Inc. shares are currently tradin... Full story

Yahoo Finance • 2 months ago

Baird downgrades Quest Diagnostics stock rating to Neutral on balanced risk/reward

Investing.com - Baird downgraded Quest Diagnostics (NYSE:DGX) from Outperform to Neutral on Monday, while maintaining a price target of $194.00. The stock, currently trading at $180.23, sits near its 52-week high of $185.62, with a market... Full story

Yahoo Finance • 2 months ago

Quest Diagnostics stock hits all-time high at 182.43 USD

Quest Diagnostics (NYSE:DGX) stock reached an all-time high of 182.43 USD, marking a significant milestone for the $20.39 billion healthcare diagnostics company. According to InvestingPro analysis, the stock is currently trading slightly a... Full story

Yahoo Finance • 2 months ago

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

SECAUCUS, N.J., Aug. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance... Full story

Yahoo Finance • 2 months ago

Daily Dividend Report: GAP,DGX,HAL,CSCO,CB

Gap today announced that its board of directors has authorized a third quarter fiscal year 2025 dividend of $0.165 per share, payable on or after October 29, 2025, to shareholders of record at the close of business on October 8, 2025. Que... Full story

Yahoo Finance • 2 months ago

Quest Diagnostics declares $0.80 dividend

* Quest Diagnostics (NYSE:DGX [https://seekingalpha.com/symbol/DGX]) declares $0.80/share quarterly dividend [https://seekingalpha.com/pr/20200419-quest-diagnostics-declares-quarterly-cash-dividend], in line with previous. * Forward yi... Full story

Yahoo Finance • 2 months ago

Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic

Company Logo The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced publ... Full story

Yahoo Finance • 2 months ago

North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers

Company Logo The North America Autoimmune Disease Diagnostics Market is projected to grow from USD 1.96 billion in 2024 to USD 3.5 billion by 2033, at a CAGR of 6.66%. Key growth drivers include rising incidence of autoimmune conditions l... Full story

Yahoo Finance • 3 months ago

Laboratory Corporation of America stock price target raised to $323 at Leerink

Investing.com - Leerink Partners has raised its price target on Laboratory Corporation of America (NYSE:LH) to $323.00 from $293.00 while maintaining an Outperform rating on the stock. The stock, currently trading at $267.46, has shown str... Full story

Yahoo Finance • 3 months ago

Nasdaq Pressured by Chip Stocks, But Broad Market Supported by Lower T-note Yields

The S&P 500 Index ($SPX) (SPY) Tuesday closed up +0.06%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.40%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.50%.  September E-mini S&P futures (ESU25) rose +0.01%, and Sept... Full story